1. RAD140, an orally available selective androgen receptor modulator, exhibits potent anti-tumor activity in ER+AR+ breast cancer models. (December 2016) Authors: Yu, Z.; Brown, J.; Saeh, J.; Hattersley, G. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗